Cours Opexa Therapeutics Inc Nasdaq
Actions
US68372T3014
Recherche biotechnologique et médicale
Dernier transcript sur Opexa Therapeutics Inc
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
R. Clifton
DFI | Director of Finance/CFO | 51 | 17/11 |
Tanya Hayden
COO | Chief Operating Officer | 44 | 01/06/21 |
John M. Klopp
CTO | Chief Tech/Sci/R&D Officer | 50 | - |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
R. Clifton
DFI | Director of Finance/CFO | 51 | 17/11 |
Joshua Schafer
BRD | Director/Board Member | 53 | 17/11 |
Varia. 1 janv. | Capi. | |
---|---|---|
+2,97% | 108 Md | |
+10,21% | 105 Md | |
+1,57% | 23,46 Md | |
-12,77% | 21,72 Md | |
-7,05% | 18,64 Md | |
-37,64% | 17,45 Md | |
-6,50% | 17,19 Md | |
+6,00% | 13,99 Md | |
+37,20% | 12,53 Md |